Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Activation of the human chemokine receptor CX3CR1 regulated by cholesterol. | Sci Adv | 2022 | 35767622 | PubTator, text mining | PubMed |
| Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection. | Front Immunol | 2022 | 35757700 | PubTator, text mining | PubMed |
| Anti-Inflammatory Effects of Cicadidae Periostracum Extract and Oleic Acid through Inhibiting Inflammatory Chemokines Using PCR Arrays in LPS-Induced Lung inflammation In Vitro. | Life (Basel) | 2022 | 35743888 | PubTator, text mining | PubMed |
| Monocyte Chemotactic Protein-1 (MCP1) Accumulation in Human Osteoclast Precursor Cultures. | Life (Basel) | 2022 | 35743820 | PubTator, text mining | PubMed |
| A BIRC5High COD1Low Cancer Tissue Phenotype Indicates Poorer Prognosis of Metastatic Breast Cancer Patients. | Cancer Inform | 2022 | 35734521 | PubTator, text mining | PubMed |
| NTN4 as a prognostic marker and a hallmark for immune infiltration in breast cancer. | Sci Rep | 2022 | 35732855 | PubTator, text mining | PubMed |
| Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates. | World J Surg Oncol | 2022 | 35729567 | PubTator, text mining | PubMed |
| RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma. | Front Mol Biosci | 2022 | 35720121 | PubTator, text mining | PubMed |
| Role of chemokine systems in cancer and inflammatory diseases. | MedComm (2020) | 2022 | 35702353 | PubTator, text mining | PubMed |
| Comprehensive Analyses of MELK-Associated ceRNA Networks Reveal a Potential Biomarker for Predicting Poor Prognosis and Immunotherapy Efficacy in Hepatocellular Carcinoma. | Front Cell Dev Biol | 2022 | 35693941 | PubTator, text mining | PubMed |
| The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies. | Front Immunol | 2022 | 35693763 | PubTator, text mining | PubMed |
| Integrin-Linked Kinase Expression Characterizes the Immunosuppressive Tumor Microenvironment in Colorectal Cancer and Regulates PD-L1 Expression and Immune Cell Cytotoxicity. | Front Oncol | 2022 | 35692780 | PubTator, text mining | PubMed |
| Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma. | Blood Adv | 2022 | 35675517 | PubTator, text mining | PubMed |
| Prognosis of chronic Chagas heart disease and other pending clinical challenges. | Mem Inst Oswaldo Cruz | 2022 | 35674528 | PubTator, text mining | PubMed |
| Viral G Protein-Coupled Receptors Encoded by β- and γ-Herpesviruses. | Annu Rev Virol | 2022 | 35671566 | PubTator, text mining | PubMed |
| Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration. | World J Clin Cases | 2022 | 35665115 | PubTator, text mining | PubMed |
| DNA methylation-regulated YTHDF2 correlates with cell migration and immune cell infiltration in glioma. | Aging (Albany NY) | 2022 | 35661004 | PubTator, text mining | PubMed |
| The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma. | BMC Immunol | 2022 | 35659256 | PubTator, text mining | PubMed |
| TGF-β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation. | Clin Transl Med | 2022 | 35652284 | PubTator, text mining | PubMed |
| Inhaled Bronchodilators and Corticosteroids in the Management of Bronchiolitis Obliterans due to Allogenic Hematopoietic Stem Cell Transplantation. | Oman Med J | 2022 | 35651501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=32